According to a recent study, the popular type-2 diabetes drug Byetta and cancer of the pancreas have been linked. In addition, patients taking the drug have an increased risk of pancreatitis, or inflammation of the pancreas. Studies on the relationship between the drug and thyroid cancer are still underway, though experts have noted an increase in the number of reports of people suffering from the disease while on the drug.
Professionals are quick to point out the need to avoid alarmism, which may cause patients to quickly cease a medication that is doing more good than harm. However, the FDA and pharmaceutical companies should ensure that the patients are educated, so they can make their own decisions when it comes to taking a possibly harmful drug.
Byetta is used to treat type 2 diabetes mellitus. It reduces high levels of glucose, while simultaneously increasing the individual’s sensitivity to insulin. The success rate of the drug has made it a popular addition to a lifestyle of people living with type 2 diabetes. It has shown significant success in treating the condition in those individuals particularly resistant to other medications. There are, however, concerns that the mechanisms of action actually coincide with some very severe complications.
Exanatide is the active ingredient in the medication and is within a class of medications called incretin mimetics. It stimulates the body to produce insulin when blood sugar levels are too high. The drug helps move the sugar in the blood to other tissues usually used immediately for energy. Basically, the medication helps the body utilize the insulin more effectively. While it is a popular medication, the patient’s medical history and the connection between Byetta and cancer must be carefully considered.
Thyroid and pancreatic carcinoma are two deadly forms of the disease, and unfortunately, they often go undiagnosed until the later stages of the disease. Other adverse effects include kidney problems, diabetic coma, and gastro distress. If someone has suffered any adverse effects and taken the medication, it may be time to think about consulting with a qualified attorney.
Since Byetta and cancer have been linked, the patient or the patient’s family may be able to get compensation and restitution for past and future damages, pain, and suffering. If the patient has been diagnosed with or died from carcinoma of the pancreas or thyroid, and has taken the medication, the drug injury lawyer will advise whether or not there is cause for a lawsuit.
It is important to note, however, that it is never advisable to stop taking any medication without first consulting with a physician.
When considering speaking with an attorney, ask about previous experience and education. Also ask if the lawyer has experience in this particular type of litigation. Byetta and cancer seem to have a strong connection, and those that have been affected may deserve compensation. The pharmaceutical company is settling most cases out of court, so many patients have received restitution for their medical expenses, pain and suffering.

Since Byetta and cancer have been linked it may be easier to win a judgment. However, the patient or patient’s survivors must consider hiring a reputable attorney to represent them. The attorney will provide consultation, and if the case is accepted, they may not demand payment until a settlement is reached. It is good to know that there may be an avenue of recourse in this type of situation.